Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term azithromycin in children with primary ciliary dyskinesia
IRCT20251007067541N1Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial in primary ciliary dyskinesia (PCD) comparing Azithromycin with Placebo (2 arms). Primary endpoints: Number of pulmonary exacerbations requiring hospitalization, Spirometry results and 3 more. Started Oct 2025; status: completed.
02
Drugs
azithromycin
03
Conditions
primary ciliary dyskinesia (PCD)
Beyond the preview
Go deeper on IRCT20251007067541N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20251007067541N1.